CLAD Deconvolved PERG Responses in Glaucoma Patients

Clinical trial NCT06388096 · UNKNOWN

Trial details

NCT number: NCT06388096
Sponsor: Jorvec Corp.
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Glaucoma, Suspect

Start date: 2023-06-01
Primary completion: 2025-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.